This chemical is primarily utilized in the development of pharmaceuticals, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the creation of compounds targeting neurological disorders, such as anxiety and depression, due to its structural compatibility with receptors in the central nervous system. Additionally, its trifluoromethyl group enhances the metabolic stability and bioavailability of the resulting drugs, making it valuable in medicinal chemistry. It is also explored in agrochemical research for designing novel pesticides and herbicides, leveraging its unique chemical properties to improve efficacy and environmental safety.